M&A
Glenmark acquires Acetylcysteine injection from Aspen Pharma
BSE Announcement Business Line
Mumbai-based Glenmark Pharmaceuticals has acquired the Abbreviated New Drug Application (ANDA) for the product Acetylcysteine Injection, Single-Dose Vials from Aspen Pharma USA Inc . and launched in the US market. The drug is a generic version developed by Cumberland Pharmaceuticals Inc.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
